{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/345149674"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "to develop drug delivery technologies, particularly the development of a significant amount of expertise in pulmonary (respiratory) drug delivery as incorporated in our lead product candidate entering Phase 3 clinical trials, Pulmaquin." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "getfilings.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/313252631"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/345149674"] } } }
